Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19 – Hematology Advisor
Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19 Hematology AdvisorEarly-phase clinical trials in a pandemic: learning from the response to COVID-19 The LancetThe severity of COVID-19 c...